Heart-protecting Musk Pill

DRUG2 trials

Sponsors

Shanghai Hutchison Pharmaceuticals Limited, Affiliated Hospital of Nantong University

Conditions

Coronary Artery DiseaseDiabetes Mellitus, Type 2Diabetic Angiopathies

Phase 4

A Trial to Evaluate Efficacy of Heart-protecting Musk Pill

Shanghai Hutchison Pharmaceuticals LimitedCoronary Artery Disease

Start: 2011-07-31End: 2015-12-31Target: 2700Updated: 2014-12-19

Effect of HMP on Diabetic Microangiopaemia in T2DM

CompletedNCT05095922

Affiliated Hospital of Nantong UniversityDiabetes Mellitus, Type 2, Diabetic Angiopathies

Start: 2023-03-28End: 2024-05-30Updated: 2024-07-09

Related Papers

Shexiang Baoxin Pill (MUSKARDIA) reduces major adverse cardiovascular events in women with stable coronary artery disease: A subgroup analysis of a phase IV randomized clinical trial

Frontiers in Cardiovascular Medicine2022-10-213 citations